Scinovex
reviewTop 1% cited

The history and future of targeting cyclin-dependent kinases in cancer therapy

Nature Reviews Drug Discovery · 2015 · Vol. 14(2) · pp. 130–146
Uzma AsgharAgnieszka K. WitkiewiczNicholas C. TurnerErik S. Knudsen
Advanced Breast Cancer TherapiesCancer-related Molecular PathwaysMicrotubule and mitosis dynamicsKinaseCyclinCancer researchTargeted therapyCancerCyclin-dependent kinaseCancer therapyMedicineOncologyBiology

MeSH terms

AnimalsAntineoplastic AgentsCell CycleClinical Trials as TopicDrug Evaluation, PreclinicalHumansNeoplasmsMolecular StructureSignal TransductionGene Expression Regulation, NeoplasticCyclin-Dependent KinasesDrug DiscoveryMolecular Targeted Therapy

Funding

  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Consortium canadien en neurodégénérescence associée au vieillissement
  • National Cancer Institute
Citations
1,738
FWCI
112.17
field-weighted impact
References
212
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The history and future of targeting cyclin-dependent kinases in cancer therapy · Scinovex